Each vertical line represents a separate cluster, and clusters are sorted by proportion of heterosexuals (HET), men who have sex with men (MSM) and people who inject drugs (PWID). Clusters which could not be classified (>50% sequences with no risk group) and sequences for which risk group was not available are not shown within cluster composition. Four groups emerged clearly: clusters which were fully heterosexual (1230/1358% of clusters), clusters which were fully MSM (31/1358,% of clusters), clusters which were a mix of heterosexuals and MSM (73/1358 % of clusters) and clusters which contained PWID (24/1358). Some PWID clusters contained MSM and heterosexuals but all contained at least 25% sequences from PWID.
Two risk group classification procedures (minority and majority definition) were tested in addition to the classification used in the paper. According to our majority risk group definition, the risk group of the cluster was that of the majority of the sequences in the cluster. If two risk groups each accounted for 50% of sequences, both risk groups were used and growth was divided proportionally between them (or attributed to the crossover risk group in the case of HET-MSM clusters). According to the minority cluster definition, the risk group of any sequence in the cluster entered the risk group classification and growth was divided proportionally between them (or attributed to the crossover risk group in the case of HET-MSM clusters). In both cases, clusters containing 50% or more sequences with unknown risk group were classified as NA.
Changing the rules of cluster risk group classification changed the risk group of only 11/1148 clusters for the minority definition and 43/1148 clusters for the majority definition (of which 29 were crossover clusters which became either HET or MSM). Differences in growth rates between risk groups were unchanged (as shown by the overlap in standard error bar) other than crossover growth rate dropping in the majority definition because most crossovers clusters were relabelled as either MSM or HET. MSM, mother to child, blood product, or unknown). Epidemiological data and sequences were linked using partial identifiers, then the data were fully anonymised and delinked before phylogenetic analysis. For patients with more than one sequence in the database the earliest sequence was used, usually obtained before the initiation of antiretroviral therapy. Subtypes were assigned using [3] . Identical sequences were removed using ElimDupes .
(http://www.hiv.lanl.gov/content/sequence/ELIMDUPES/elimdupes.html) as duplicate sequences are highly unlikely to come from different patients.
As submission of the entire sequence dataset to public databases would permit transmission network identification and thus risk breaching patient confidentiality, we have followed earlier practice [4] and submitted a random sample of 10% of each subtype to GenBank under accession numbers KU498303 -KU499411.
